butylscopolammonium bromide has been researched along with Lung Diseases, Obstructive in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Albrecht, B; Beauchamp, G; Chevigny, M; de Lagarde, M; Lavoie, JP; Rodrigues, N | 1 |
1 trial(s) available for butylscopolammonium bromide and Lung Diseases, Obstructive
| Article | Year |
|---|---|
N-butylscopolammonium bromide causes fewer side effects than atropine when assessing bronchoconstriction reversibility in horses with heaves.
Topics: Animals; Atropine; Bronchoconstriction; Butylscopolammonium Bromide; Cross-Over Studies; Female; Horse Diseases; Horses; Lung Diseases, Obstructive; Male; Parasympatholytics | 2014 |